📖

PSP Therapeutic Ideas

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-therapeutics-psp-therapeutic-ideas
Related Entities
therapeutics-psp-therapeutic-ideas
Metadata
slugtherapeutics-psp-therapeutic-ideas
entity_typetreatment
kg_node_idNone
Linked Artifacts (143)
mentions🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis90%
related🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis90%
mentions🧫4R-Tau Targeting Therapies for PSP and CBS80%
mentions🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri80%
mentions🧫Brainstem Circuit Modulation for PSP80%
mentions🧫Levodopa Response Determinants in PSP — Biomarker-Guided Pre80%
mentions🧫PSP and CBS Biomarker Validation Study80%
mentions🧫Tau Pathology Initiation Zone Identification80%
mentions🧫Tau Spreading Network Mapping via Spatial Transcriptomics in80%
mentions🔬PSP and CBD both involve 4R-tau but produce distinct neuropa75%
related🧫4R-Tau Targeting Therapies for PSP and CBS72%
related🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri72%
related🧫Brainstem Circuit Modulation for PSP72%
related🧫Levodopa Response Determinants in PSP — Biomarker-Guided Pre72%
related🧫PSP and CBS Biomarker Validation Study72%
related🧫Tau Pathology Initiation Zone Identification72%
related🧫Tau Spreading Network Mapping via Spatial Transcriptomics in72%
mentions🧫s:** - Test tau spreading in AQP4 knockout vs wild-type mice70%
mentions🧫s:** - Compare tau strain spreading in EXT1/EXT2 conditional70%
mentions🧫Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy70%
mentions🧫CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi70%
mentions🧫CRISPR Gene Correction Approaches for CBS/PSP70%
mentions🧫N-of-1 Clinical Trial Design for CBS/PSP70%
mentions🧫Tau PET Pattern as Therapeutic Response Predictor in 4R-Tauo70%
mentions🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides70%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%
related🧫Animal Model Comparison for Neurodegenerative Disease Therap70%
related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#70%
related🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&70%
related🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag70%
related🧫Neural Oscillation Dysfunction Validation in Parkinson'70%
related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#70%
related🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin70%
related🧫Protein Aggregation Kinetic Validation Results70%
related🧫Purinergic Signaling Dysfunction Validation in Parkinson70%
related🧫Regulated Necrosis Validation Study in Parkinson's Dise70%
related🧫Stress Granule Dysfunction Validation in Parkinson's Di70%
related🧫Experiment Validation: In vitro ThT Assay70%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%
related🧫Animal Model Comparison for Neurodegenerative Disease Therap70%
related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#70%
related🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&70%
related🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag70%
related🧫Neural Oscillation Dysfunction Validation in Parkinson'70%
related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#70%
related🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin70%
related🧫Protein Aggregation Kinetic Validation Results70%
related🧫Purinergic Signaling Dysfunction Validation in Parkinson70%
related🧫Regulated Necrosis Validation Study in Parkinson's Dise70%
related🧫Stress Granule Dysfunction Validation in Parkinson's Di70%
related🧫Experiment Validation: In vitro ThT Assay70%
related🧫4R-Tau Targeting Therapies for PSP and CBS70%
related🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri70%
related🧫Brainstem Circuit Modulation for PSP70%
related🧫Levodopa Response Determinants in PSP — Biomarker-Guided Pre70%
related🧫PSP and CBS Biomarker Validation Study70%
related🧫Tau Pathology Initiation Zone Identification70%
related🧫Tau Spreading Network Mapping via Spatial Transcriptomics in70%
related🔬PSP and CBD both involve 4R-tau but produce distinct neuropa67%
mentions🧪Astrocyte-Mediated Neuronal Epigenetic Rescue65%
related🧫s:** - Test tau spreading in AQP4 knockout vs wild-type mice63%
related🧫s:** - Compare tau strain spreading in EXT1/EXT2 conditional63%
related🧫Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy63%
related🧫CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi63%
related🧫CRISPR Gene Correction Approaches for CBS/PSP63%
related🧫N-of-1 Clinical Trial Design for CBS/PSP63%
related🧫Tau PET Pattern as Therapeutic Response Predictor in 4R-Tauo63%
related🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides63%
mentions🔬What are the mechanisms underlying 4r-tau strain-specific sp60%
related🧪Astrocyte-Mediated Neuronal Epigenetic Rescue58%
related🔬What are the mechanisms underlying 4r-tau strain-specific sp54%
mentions🧫Microtubule domain analysis in adult axons50%
mentions🧫Tau depletion effects on neuronal development in primary cul50%
mentions🧫Pre-Symptomatic Tau Detection in MAPT Mutation Carriers50%
mentions🧪TREM2 Conformational Stabilizers for Synaptic Discrimination50%
mentions🧪TREM2-mediated microglial tau clearance enhancement50%
mentions🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer50%
mentions🧪APOE Isoform Conversion Therapy50%
mentions🧪APOE4 Allosteric Rescue via Small Molecule Chaperones50%
mentions🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction50%
mentions🧪Targeted APOE4-to-APOE3 Base Editing Therapy50%
mentions🧪APOE4-Selective Lipid Nanoemulsion Therapy50%
mentions🧪Competitive APOE4 Domain Stabilization Peptides50%
mentions🧪APOE Isoform Expression Across Glial Subtypes50%
mentions🧪TREM2-Dependent Microglial Senescence Transition50%
mentions🧪Cell-Type Specific TREM2 Upregulation in DAM Microglia50%
mentions🧪Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬What are the mechanisms underlying synaptic pruning by micro50%
related🔬What are the mechanisms underlying mitochondrial transfer be50%
related🔬Investigate prion-like spreading of tau pathology through co50%
related🔬The disease-associated microglia (DAM) phenotype involves TR50%
related🔬What are the mechanisms underlying tdp-43 phase separation t50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
related🔬What are the mechanisms underlying apoe4 structural biology 50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬What are the mechanisms underlying synaptic pruning by micro50%
related🔬What are the mechanisms underlying mitochondrial transfer be50%
related🔬Analyze circuit-level changes in neurodegeneration using All50%
related🔬The disease-associated microglia (DAM) phenotype involves TR50%
related🔬Is disrupted sleep a cause or consequence of neurodegenerati50%
related🔬Is disrupted sleep a cause or consequence of neurodegenerati50%
related🔬CRISPR-based therapeutic approaches for neurodegenerative di50%
related🔬What cell types are most vulnerable in Alzheimer's Dise50%
related🔬Investigate prion-like spreading of tau pathology through co50%
related🔬What are the mechanisms by which tau pathology spreads throu50%
related🔬How does metabolic reprogramming (glucose metabolism shifts,50%
related🔬What are the most promising therapeutic strategies for targe50%
related🔬TDP-43 undergoes liquid-liquid phase separation that becomes50%
related🔬Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph50%
related🔬Multiple NDDs converge on autophagy-lysosome dysfunction. Ar50%
related🧪APOE-TREM2 Interaction Modulation50%
related🧪TREM2-Mediated Selective Aggregate Clearance Pathway50%
related🔬What are the mechanisms underlying protein aggregation cross50%
related🔬What are the mechanisms underlying mechanistic role of apoe 50%
mentions🧫AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi44%
mentions🧫AD Combination Therapy Trial: Anti-Aβ + Anti-Tau44%
mentions🧫Sex Differences in Alzheimer's Disease — mechanisms and44%
mentions🧫Mouse Cdk5, p35, and p39 mutations in neuronal migration44%
mentions🧫Epigenetic Regulation Dysfunction in Alzheimer's and Pa44%
mentions🧫Microglial TREM2 Agonist In Vivo Efficacy44%
mentions🧫TREM2 Agonist Therapy for Parkinson's Disease — Experim44%
mentions🧫TREM2 Function in Alzheimer's Disease — From Risk Varia44%
mentions🔬CRISPR-based therapeutic approaches for neurodegenerative di40%
mentions🔬Investigate prion-like spreading of tau pathology through co40%
mentions🔬The disease-associated microglia (DAM) phenotype involves TR40%
mentions🔬What are the mechanisms underlying apoe4 structural biology 40%
mentions🔬Analyze circuit-level changes in neurodegeneration using All40%
mentions🔬The disease-associated microglia (DAM) phenotype involves TR40%
mentions🔬Is disrupted sleep a cause or consequence of neurodegenerati40%
mentions🔬Is disrupted sleep a cause or consequence of neurodegenerati40%
mentions🔬What cell types are most vulnerable in Alzheimer's Dise40%
mentions🔬What are the mechanisms by which tau pathology spreads throu40%
mentions🔬How does metabolic reprogramming (glucose metabolism shifts,40%
mentions🔬What are the most promising therapeutic strategies for targe40%
mentions🔬TDP-43 undergoes liquid-liquid phase separation that becomes40%
mentions🔬Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph40%
mentions🔬Multiple NDDs converge on autophagy-lysosome dysfunction. Ar40%
mentions🔬What are the mechanisms underlying tdp-43 phase separation t40%
mentions🔬What are the mechanisms underlying blood-brain barrier trans40%
related🧪TREM2 Conformational Stabilizers for Synaptic Discrimination40%
related🧪Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m40%
related🧪TREM2-mediated microglial tau clearance enhancement40%